↓ Skip to main content

Cochrane Database of Systematic Reviews

Pharmacotherapies for cannabis dependence

Overview of attention for article published in Cochrane database of systematic reviews, December 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

blogs
2 blogs
policy
2 policy sources
twitter
9 tweeters
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
200 Mendeley
Title
Pharmacotherapies for cannabis dependence
Published in
Cochrane database of systematic reviews, December 2014
DOI 10.1002/14651858.cd008940.pub2
Pubmed ID
Authors

Kushani Marshall, Linda Gowing, Robert Ali, Bernard Le Foll

Abstract

Cannabis is the most prevalent illicit drug in the world. Demand for treatment of cannabis use disorders is increasing. There are currently no pharmacotherapies approved for treatment of cannabis use disorders.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 200 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Brazil 1 <1%
Unknown 198 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 17%
Student > Ph. D. Student 30 15%
Researcher 30 15%
Student > Bachelor 23 12%
Student > Doctoral Student 17 9%
Other 46 23%
Unknown 21 11%
Readers by discipline Count As %
Medicine and Dentistry 74 37%
Psychology 31 16%
Nursing and Health Professions 17 9%
Pharmacology, Toxicology and Pharmaceutical Science 12 6%
Neuroscience 9 5%
Other 25 13%
Unknown 32 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2020.
All research outputs
#763,451
of 17,358,590 outputs
Outputs from Cochrane database of systematic reviews
#1,968
of 11,660 outputs
Outputs of similar age
#14,212
of 312,832 outputs
Outputs of similar age from Cochrane database of systematic reviews
#54
of 246 outputs
Altmetric has tracked 17,358,590 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 312,832 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 246 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.